Cells depend on specific stimuli, such as trophic factors, for survival and in the absence of such stimuli, undergo apoptosis. How do cells initiate apoptosis in response to the withdrawal of trophic factors or other dependent stimuli? Recent studies of apoptosis induction by neurotrophin withdrawal argue for a novel form of pro-apoptotic signal transduction ±`negative signal transduction' ± in which the absence of ligand-receptor interaction induces cell death. We have found that the prototype for this form of signaling ± the common neurotrophin receptor, p75 NTR ± creates a state of cellular dependence (or addiction) on neurotrophins, and that this effect requires an`addiction/dependence domain' (ADD) in the intracytoplasmic region of p75 NTR . We have recently found other receptors that include dependence domains, arguing that dependence receptors, and their associated dependence domains, may be involved in a rather general mechanism to create cellular states of dependence on trophic factors, cytokines, adhesion, electrical activity and other dependent stimuli.
Apoptosis and negative signal transduction
Cells, especially during development, may depend on specific stimuli for their survival, such as trophic factors, cytokines, adhesion, hormones, or electrical activity. Mature cells may in many cases be more resistant to the loss of these stimuli, but often retain at least some degree of dependence on such stimuli. In the absence of the requried stimulus, the dependent cells undergo apoptosis, so the cells are quite literally addicted to the stimulus or stimuli. For example, developing cerebellar granule cells require depolarization for survival, and undergo apoptosis readily in the absence of depolarization (Chang and Wang, 1997; Miller et al, 1997) .
It has generally been assumed that apoptosis resulting from a lack of such stimuli is simply due to the lack of a positive survival signal, such as that initiated by tyrosine phosphorylation of the Trk receptors and the resultant downstream signaling. While this undoubtedly accounts for part of the effect, results obtained over the past few years argue for a distinct and complementary form of signal transduction (Rabizadeh et al, 1993; Bredesen and Rabizadeh, 1997; Rabizadeh et al, unpublished observations) . Moreover, since apoptosis is an active form of cell death, the signal initiating this active program must be generated or propagated in some way as a result of the lack of binding of growth factor, cytokine, or other dependent stimulus. However, despite the biological rationale for such`negative signal transduction' ± i.e., signaling resulting from the absence of binding of a ligand to its receptor ± this form of pro-apoptotic signal transduction has not been appreciated previously.
The recognition of this novel form of signal transduction raises a number of questions: How might an unbound receptor participate in signal transduction? How long might a receptor`wait' for ligand binding before initiating or mediating a death signal? Might this form of signal transduction utilize similar pathways to those of classical signal transduction? Our work to date argues that negative signal transduction' differs from classical signal transduction in critical aspects: for example, in classical signal transduction receptors serve to bind ligand and then initiate a signal; in contrast, in negative signal transduction, molecules that serve as`receptors' for the classical arm of a negative signal transduction pathway may serve as downstream mediators of the signal propagated along the negative signaling arm of a bifid pathway. Feedback loops create a two-state (or multistate) system that tends toward one stable state over the other(s) by a combination of feedback inhibition of the alternative arm(s) and feedforward enhancement of the designate arm.
p75
NTR , the prototype addiction/ dependence receptor
In 1993, we reported that p75 NTR , the common neurotrophin receptor, induces apoptosis in the absence of ligand binding, with apoptosis being inhibited by ligand binding. We have reported similar results recently for a related receptor, CD40 (Ruan et al, 1997) . This novel profile suggested that p75 NTR creates a state of cellular dependence, or addiction, on neurotrophins (Figure 1 ). This concept has been supported by data from p75 null (`knockout') mice (Sauer et al, 1996; Yeo et al, 1997) , as well as by in vivo antisense experiments (Cheema et al, 1996) . Sauer et al (1996) found that mice deficient in NGF display atrophy and hypoplasia of medial septal cholinergic neurons, but that crossing those NGF hemizygous mice with p75
NTR null mice restored cell size and number to that of the p75 NTR null mice, i.e., to supranormal. They concluded that, in the presence of a reduced concentration of NGF, p75
NTR mediates a reduction in cholinergic neuronal number and size in the medial septal region.
Recent results from Yeo et al (1997) are compatible with those of Sauer et al (1996) : p75 null mice were found to have a 50% increase in cholinergic neuronal number in the diagonal band and medial septal region, with an increase in somal volume of approximately 30%. Perry Bartlett and Graham Barrett, along with their colleagues, found that the use of antisense oligonucleotides to decrease p75 expression also blocks neuronal apoptosis in another paradigm of neurotrophin-withdrawal-induced death, that of axotomy-induced neuronal cell death (Cheema et al, 1996) .
Not surprisingly, the dependent state created by p75 NTR is relative rather than absolute. For example, the withdrawal of NGF from PC12 cells leads to apoptosis that can be blocked by downregulation of p75 NTR (Rabizadeh and Bredesen, 1994; Barrett and Georgiou, 1996) or expression of bcl-2 (Mah et al, 1993; Martinou et al, 1992) . Thus, the net effect is that p75 NTR expression in the absence of neurotrophin alters the cellular apostat (Bredesen, 1996; Salvesen and Dixit, 1997) , enhancing the likelihood of apoptosis. It is of course possible that the same effect will be associated with binding of an antagonistic ligand, rather than the lack of binding of an agonist, but, in the case of p75 NTR , neurotrophin withdrawal is not currently known to be associated with the binding of a neurotrophin-antagonist ligand; nonetheless, this remains a formal possibility.
The effect of p75 NTR on cellular neurotrophin dependence may underlie aspects of both neural and extraneural cellular behavior: for example, prostate epithelial cells express p75 NTR , which we have argued (Bredesen, 1994 ) ties them to a source of neurotrophin, supplied by the stromal cells. Pflug et al (1992) found a progressive decrease in p75 NTR expression associated with the development of prostate neoplasia, with cell lines from metastatic prostate carcinomas failing to express p75 NTR . We have found that the re-expression of p75 NTR in PC3 prostate carcinoma cells restores a state of neurotrophin dependence, resulting in apoptosis if NGF is not supplied (Rabizadeh et al, unpublished observations) . Thus, p75 NTR may play a role in both neural and extraneural cellular paradigms that share the common thread of neurotrophin dependence.
An addiction/dependence domain (ADD) in p75 NTR
What is the mechanism by which p75 NTR expression creates a state of neurotrophin dependence? Site-directed mutagenesis studies of p75 NTR have identified a region within the intracellular domain that is required for the creation of cellular neurotrophin dependence (Rabizadeh et al, unpublished observations) . This region is referred to as an`addiction domain' or`dependence domain', since it is required for the induction of apoptosis by p75 NTR in the absence of NT binding (`addiction' implies that the cells have been exposed to the NT prior to their requirement for it, whereas`dependence' does not. We have used these non-equivalent terms interchangeably here because p75 NTR can create a state of cellular NT dependence in cultured cells, but in vivo, p75 NTR expression may follow neurotrophin exposure, and hence in that case the cellular state may more accurately be called an`addiction' than a`dependence'). Deletions that include the addiction/ Figure 1 Creation of a neurotrophin-dependent cellular state by expression of p75 NTR , the common neurotrophin receptor. The likelihood of undergoing apoptosis (setting of the cellular`apostat') is increased by p75 NTR expression, but this effect can be blocked either by binding of neurotrophins to p75 NTR or by downregulation of p75 NTR . In the absence of neurotrophin, p75 NTR is activated, and, in a process that requires the addiction/dependence domain (ADD), triggers apoptosis. Activation of p75 triggers, through an intermediate, both further activation of p75 and apoptosis, creating a positive feedback loop. NT, neurotrophin; PTM, post-translational modification p75 NTR and neurotrophin dependence DE Bredesen et al dependence domain (ADD), and point mutations within this region, both destroy the Trk-independent intrinsic receptor effect (IRE ) on apoptosis. Furthermore, the ADD synthesized as a peptide is a relatively potent pro-apoptotic peptide (Hileman et al, 1997; Rabizadeh et al, unpublished observations) . Thus the ADD is both necessary and sufficient for apoptosis induction. Control peptides, including a scrambled p75 NTR ADD peptide, mutant p75 peptides, p75-derived peptides from outside the ADD, and control peptides matched for predicted helicity, all failed to induce apoptosis. Mutations that affect the ability of the ADD peptide to induce apoptosis have parallel effects when introduced into the full-length p75 NTR , further supporting the importance of the ADD in apoptosis induction by p75 NTR (Rabizadeh et al, unpublished observations) .
In a cell-free system of neuronal apoptosis (Ellerby et al, 1997) , the p75 NTR ADD peptide induces apoptosis, as assessed by caspase activation, mitochondrial cytochrome c release, and other apoptosis parameters (Rabizadeh et al, unpublished observations) . However, control peptides did not induce the neural cell-free system. This system should allow a determination of the organellar and molecular requirements for apoptosis induction by the p75 neurotrophin addiction domain.
Solution structure of fragments of the intracellular region of p75 NTR have recently been obtained (Liepinsh et al, 1997; Hileman et al, 1997) . These have disclosed predominantly a-helical structure in the terminal two-thirds of the p75 NTR intracellular domain. Liepinsh et al (1997) identified six alpha helices, a1 ± a6, in this region of p75 NTR . They pointed out that this region of p75 NTR is reminiscent of the death domain of Fas, but that there are important structural and functional differences. Whereas Fas and TNFR I have death domains of subtype I, the putative p75 NTR death domain is of subtype II. Type I death domains display the following characterisics:
1. Binding by ligand induces a pro-apoptotic signal. 2. Self association. 3. Speci®c arrangement of six alpha helices.
In contrast, the term`death domain' applied to type II death domains may turn out to be a misnomer. For example, one of the subunits of NFkB displays a type II death domain, but the expression of NFkB inhibits, rather than induces, apoptosis (Van Antwerp et al, 1996; Beg and Baltimore, 1996) . Furthermore, we have found that mutation of conserved residues in p75 NTR whose analogous residues are required for apoptosis induction by Fas and TNFR I ± not only point mutations but even large deletions ± have no effect on apoptosis induction by p75 NTR following ligand withdrawal (Rabizadeh et al, unpublished observations) .
An additional distinction between apoptosis induction by Fas and p75 NTR relates to the requirement for multimerization: for both Fas and TNFR I, multimerization is required for apoptosis induction. However, for p75 NTR , recent studies utilizing FK binding protein chimeras have shown that the monomeric receptor is required for apoptosis induction, whereas multimerization blocks apoptosis induction (Wang et al, unpublished observations; Rabizadeh et al, unpublished observations) ± just the reverse of the situation for Fas and TNFR I.
Therefore, we have argued that p75 NTR has a neurotrophin addiction domain (ADD; Figures 1 and 2 ) that is distinct from its putative death domain; whether or not it also has a functional death domain remains to be determined, but certainly the studies by Casaccia-Bonnefil et al (1996) and Frade et al (1996) would argue that it does. However, Liepinsh et al (1997) found no tendency toward self-aggregation for the putative death domain, which is further confirmation that the putative p75 NTR death domain is unlike the type I death domains of Fas and TNFR I.
Helix formation may be crucial to the pro-apoptotic effect of p75 NTR , since disruption of helix formation in the p75 NTR ADD destroys the pro-apoptotic effect of p75 NTR . However, additional mutants of the p75 NTR ADD must be tested to establish this possibility conclusively.
In theory, it should be possible to create states of cellular dependence on other ligands by fusing the p75 ADD to the extracellular and transmembrane domains of other receptors such as the EGFR; such studies are underway.
Other dependence receptors

p75
NTR represents a prototype dependence receptor. Identification and analysis of other functionally similar dependence receptors would be advantageous, in part because this may help to shed light on the p75 NTR dependence mechanism, and in part because it may provide an indication of the breadth of cellular utilization of dependence receptors.
Recently, we have found that the androgen receptor (AR) is a dependence receptor similar to p75 NTR in functional effect, even though the two receptors are not NTR neurotrophin addiction domain (ADD NT ), based on work by Hileman et al (1997) and Rabizadeh et al (unpublished observations) . The orange region highlights a mutation that, in the context of the peptide, destroys both helix formation and pro-apoptotic effect (Hileman et al, 1997) p75 NTR and neurotrophin dependence DE Bredesen et al structurally similar (Ellerby et al, unpublished observations) . Expression of the AR in cells lacking endogenous AR expression induced the cells to become androgen dependent; apoptosis was induced in the absence of testosterone, but inhibited in the presence of testosterone. Furthermore, the AR has an androgen dependence domain (ADD A , to distinguish it from the p75 NTR ADD NT ), and, just as for p75 NTR , a pro-apoptotic peptide sequence is embedded in the AR.
Studies of the AR may shed light on the mechanism by which dependence receptors create cellular states of dependence: we have found that the AR undergoes posttranslational modification (PTM), without which apoptotis induction is markedly reduced. Testosterone inhibits both the PTM and apoptosis induction; furthermore, inhibition of AR PTM by mutagenesis of the AR also blocks apoptosis induction (Ellerby et al, unpublished observations) .
We have identified the same PTM in p75 NTR , suggesting that the mechanism of apoptosis induction by these two dependence receptors may, at least in principle, be similar.
Subapoptotic dependence effects of p75 NTR
The initial studies of p75 NTR effects on cell death showed that cells overexpressing p75 NTR in the absence of trophic factor support undergo neurite retraction and atrophy as well as apoptosis (Rabizadeh et al, 1993 ; Rabizadeh et al, unpublished results), but it was assumed that the atrophy and neurite retraction simply occurred as the immediate forerunners of apoptosis. Somewhat surprisingly, however, studies in p75 NTR null mice have confirmed that p75 NTR expression may indeed lead to neuronal atrophy and synapse loss in surviving, i.e., non-apoptotic (and apparently longlived) cells, in addition to decreasing neuronal number (Yeo et al, 1997) . It is tempting to speculate that such changes may represent a stable pre-apoptotic state, i.e., that the cellular biochemical changes resulting from p75 NTR expression that lead, in the extreme, to apoptosis, may in some cases have subapoptotic manifestations that include neuronal atrophy and alterations in neurite outgrowth. However, it is not yet clear whether the p75 ADD NT mediates neuronal atrophy and synapse loss, or whether a different p75 NTR region is required for those effects.
A role for dependence receptors in input/output matching?
Studies of p75
NTR in vivo, employing p75 null mice, have produced widely varying results. Lack of p75 NTR expression may result in an increase in medial septal neuronal number (Peterson et al, 1997; Yeo et al, 1997) , no increase, or a slight decrease (Peterson et al, 1997) ; it may result in an increase in striatal ChAT activity (Van der Zee et al, 1996) or no change in striatal ChAT activity (Yeo et al, 1997) . In the dorsal root ganglia, lack of p75 NTR may lead to fewer neurons (Lee et al, 1992) , but may also inhibit apoptosis (Greene and Kaplan, 1995) . How can such disparate results be reconciled?
Recent work (Sauer et al, 1996) may shed some light on these apparent discrepancies. Sauer et al (1996) found that NGF hemizygotes, with a reduction in NGF concentration, demonstate both neuronal atrophy and a decrease in medial septal cholinergic neuronal number. This pattern thus represents essentially the inverse of the findings in the p75 NTR null mice. However, crossing of the NGF hemizygotes with the p75 NTR null mice produced mice with medial septal cholinergic neuronal sizes and numbers indistinguishable from the p75 NTR nulls, i.e., with increases in neuronal size and number. The authors concluded that, in the presence of a reduced concentration of NGF, p75 NTR mediates neuronal atrophy and loss. Interestingly, their work demonstrates that, in the absence of p75 NTR , medial septal neuronal size and number are independent of NGF concentration over the range of concentrations represented by the NGF hemizygotes and homozygotes. If one constructs an idealized graph of these results (Figure 3) , it becomes apparent that p75 NTR is likely to serve a role in input/output matching, in which the input is ligand and the output controls neuronal size, survival, and synaptogenesis. In other words, in the presence of p75 NTR , neuronal size, and probability of undergoing apoptosis, are matched to the NGF availability; but in the absence of p75 NTR , this input/ output matching does not occur.
The curves shown in Figure 3 may help to explain the disparate results obtained by the different groups: in A, an increase is depicted in neuronal size and number in the p75 NTR nulls due to the loss of cell number and size mediated by p75 NTR in the presence of a reduced NGF concentration. This was the result reported by Sauer et al (1996) . B depicts an increase in neuronal size and number in the p75 nulls on a homozygous NGF background in which NGF concentration is still limiting. This result is similar to those reported by van der Zee et al (1996) and Yeo et al (1997) . C depicts a lack of difference (insignificant decrease) for the p75 NTR nulls on a homozygous NGF background, in which a higher concentration of NGF than in B is present. Such a minimal decrease in neuronal number for the p75 NTR nulls was reported for TrkA + septal neurons by Peterson et al (1997) . D depicts a decrease in neuronal size and number for the p75 NTR nulls in a setting in which NGF concentration, in a homozygote, is relatively high. This result is reminiscent of that reported by Peterson et al (1997) for septal neurons.
Neurotrophin-induced vs neurotrophin withdrawal-induced apoptosis: is there really a controversy?
The initial reports that p75 NTR mediates neural apoptosis induced by trophic factor withdrawal appeared in 1993 and 1994 (Rabizadeh et al, 1993; Barrett and Bartlett, 1994; Rabizadeh and Bredesen, 1994) . Some subsequent reports have described cell death induced by neurotrophins rather than by NT withdrawal (von Bartheld et al, 1994; Frade et al, 1996; Casaccia-Bonnefil et al, 1996) . Are these reports really at odds?
It is well established that NGF withdrawal may induce apoptosis in responsive neural populations (Martin et al, 1988) . This effect is not explained by the finding that NGF may, under certain circumstances, enhance apoptosis. The argument that p75
NTR is a mediator of NT withdrawalinduced apoptosis is based on the following observations:
Overexpression of p75
NTR in neural cells enhances apoptosis induced by serum withdrawal (Rabizadeh et al, 1993) . 2. PC12 mutants that do not express p75 NTR have a reduced apoptotic response to serum withdrawal, whereas those that retain p75 NTR expression retain the apoptotic response. Return of p75 NTR expression to the p75-negative mutants returns their apoptotic response (Rabizadeh et al, 1993) . 3. Cell sorting of PC12 cells into those with high and low expression of p75 NTR demonstrates a correlation with high and low propensity to undergo apoptosis following serum withdrawal (Rabizadeh and Bredesen, 1994; Barrett and Georgiou, 1996) . 4. Antisense inhibition of p75 NTR expression is associated with inhibition of apoptosis induced by serum withdrawal, both in cell lines and primary cultures of dorsal root ganglion neurons (Barrett and Bartlett, 1994; Rabizadeh and Bredesen, 1994; Barrett and Georgiou, 1996) . 5. Expression of p75 NTR in NIH3T3 cells, which do not express Trk family members, enhances apoptosis following serum withdrawal. This effect is inhibited by NGF, BDNF, and NT-3, but affected only minimally by a mutant NGF (Ibanez et al, 1992) that binds Trk but binds p75 NTR with 100-fold lower af®nity than NGF binds p75 NTR (Rabizadeh and Bredesen, 1994) .
6. A peptide that binds p75 NTR inhibits NGF withdrawalinduced death in cultures of dorsal root ganglion cells . This peptide has no effect on similar cultures from p75-null mice. 7. As noted above, mice with reduced NGF expression due to NGF hemizygosity have a reduced number and size of medial septal cholinergic neurons, but this is rescued by crossing with p75-null mice (Sauer et al, 1996) .
Thus, there is little argument that NT withdrawal can lead to neuronal apoptosis, or that NTs generally inhibit apoptosis, and, based on the results listed above, it is highly likely that p75 NTR plays a mediating role. This is not to say that other mediators may not also be discovered.
On the other hand, it is also clear that, under certain circumstances, NGF can enhance cell death by an unknown mechanism in which p75 NTR participates. The assumption that p75 NTR cannot mediate both NT withdrawal-induced apoptosis and, under different conditions, NGF-induced apoptosis, ignores both a large volume of data and the complexity of the systems involved. Indeed, some other members of the p75 NTR /TNFR family, such as the TNF receptors, can induce or inhibit apoptosis following ligand binding (Cheng et al, 1994) .
How might p75 NTR mediate both NT withdrawal-induced apoptosis and NGF-induced apoptosis? This is currently a matter of speculation. Based on a comparison of p75 NTR effects on cells that also express Trk family members with p75 NTR effects on Trk-negative cells, we have previously suggested that p75 NTR displays two general types of proapoptotic effects:
1. An intrinsic receptor effect (IRE), activated by NT withdrawal, that occurs both in the presence and absence of Trk (although Trk may inhibit this effect, so that it may be less pronounced in the presence of Trk). 2. Trk-dependent effects, which represent the sum of the following: (a) High-af®nity binding of NTs by the combination of p75 NTR and Trk (Hempstead et al, 1991) . This effect implies that a decrease in p75 NTR will decrease high-af®nity binding of NTs, enhancing apoptosis induction at limiting NT concentrations. (b) Mutual repression of signaling by p75 NTR and Trk, such that signaling via either alone is inhibited by the other, unless the mutal repression is relieved by binding of the appropriate NT to both p75 NTR and the co-expressed Trk (Bredesen and Rabizadeh, 1996) . Competition from a mismatched NT thus leads to a net pro-apoptotic effect. (c) A decrease in Trk phosphorylation in the presence of p75 NTR (Kaplan and Miller, 1997) .
It is noteworthy that the reports of NGF-induced apoptosis have occurred in systems in which mismatched Trk members were expressed (TrkB or TrkC), or in which TrkB and TrkC expression were not evaluated. Thus, it will be of interest to determine whether or not NGF-induced apoptosis requires the expression of a mismatched Trk family member. Taglialatela et al (1996) found that BDNF inhibited, rather than induced, apoptosis in PC12 cells, but that this occurred only with a high p75 NTR : TrkA ratio (approximately 70 : 1), which in the reported experiments was achieved through the use of antisense oligonucleotides. Similarly, Cortazzo et al (1996) found that neuroblastoma cells with a high p75 NTR : Trk ratio (approximately 100 : 1) were inhibited from undergoing apoptosis, rather than induced to undergo apoptosis, by binding p75
NTR to the exclusion of TrkA. In neuroblastoma cells lacking Trk expression, Bunone et al (1997) found that p75 NTR induced apoptosis, and NGF inhibited apoptosis. Thus Taglialatela et al (1996) , Cortazzo et al (1996) , and Bunone et al (1997) all reported the inverse of the model's predictions.
The second model (Dechant and Barde, 1997) proposed that signaling through Trk is anti-apoptotic, whereas signaling through p75 NTR is pro-apoptotic. Again, published results clearly exclude this model. In addition to the studies of Taglialatela et al (1996) , Cortazzo et al (1996) , and Bunone et al (1997) quoted above, Longo et al (1997) developed a peptide that binds p75 NTR but not Trk. This peptide was shown to block the apoptosis of dorsal root ganglion neurons in primary culture, demonstrating that binding to p75 NTR may initiate an anti-apoptotic signal. Interestingly, the peptide was only effective as a cyclic dimer, with the monomer being inactive; this finding argues that p75 NTR dimerization is crucial to the initiation of an anti-apoptotic signal.
The FK binding protein results quoted above argue that, at least in some paradigms, monomeric p75 NTR is required for apoptosis induction, and that dimerization blocks the pro-apoptotic effect. However, whether or not this will be the case in neurons in vivo remains to be seen.
Conclusions p75 NTR
, the common neurotrophin receptor, is a prototypic dependence receptor. The characteristics of receptors with this newly recognized effect include the following:
1. Expression in the absence of the dependent ligand shifts the cellular apostat toward a greater probability of apoptosis. 2. Ligand binding blocks the pro-apoptotic effect. 3. These receptors include novel domains referred to as addiction domains or dependence domains (ADDs), which are required for apoptosis induction by the receptors in the absence of ligand. These ADDs are distinct from death domains. 4. Peptides representing ADDs are pro-apoptotic.
p75
NTR may also mediate subapoptotic events such as somal size specification and synaptogenesis (the latter perhaps via an effect on neurite retraction).
In some cases, NGF may induce, rather than inhibit, apoptosis. Whether this effect will turn out to require the coexpression of a mismatched Trk (TrkB or TrkC) with p75 NTR remains to be determined.
